The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in 270 Thai patients
Objective: To compare the clinical characteristics and treatment outcomes after injecting Botulinum neurotoxin type A (BoNT-A) between non-troublesome and troublesome hemifacial spasm (HFS) in Thais.…The short-term effect of combined facial exercise with botulinum toxin A injection in clinical practice in Thai patients with hemifacial spasm: A randomized controlled pilot crossover study
Objective: To compare the efficacy of combined facial exercise with BTX-A injection with BTX-A injection alone measured by the total HFS-30 (tHFS-30) score. Background: Hemifacial…Hemifacial spasm management: 26-year experience
Objective: To analyze the causes of hemifacial spasm as well as the efficacy and safety of long term treatment with botulinum toxin (BT). Background: Hemifacial…A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin
Objective: To report a case with hemimasticatory spasm responsive to serial botulinum toxin injections. Background: Hemimasticatory spasm is a rare neurologic disorder characterized by involuntary…Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm
Objective: To compare effect of cold compression and no cold compression before Botulinum neurotoxin (BoNT) injection on severity, frequency of hemifacial spasm (HFS) and complication…Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study
Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients
Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm
Objective: To investigate the differences of non-motor symptoms and the alteration of intrinsic brain networks in patients with blepharospasm and hemifacial spam. Background: Blepharospasm (BSP)…Assessing hemifacial spasm: The HFSG scale
Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm
Objective: To study demographic and clinical features of primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.